Head and Neck Cancer Market 2020 Size, Demand, Share, Regional Insight Growing Volume, Product & Service, Technology, Indication And End-User

Cancer is a life-threatening disease in which the growth of the cell is abnormal and uncontrollable which leads to the formation of a tumor.  Head and neck cancer is the terminology used to define several different malignant tumors that develop in or around the throat, larynx, nose, sinuses, and mouth.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/530

Head and neck cancer can be defined as tumor develop near the head and neck and can be caused by various factors such as Chewing tobacco, excessive alcohol consumption, and infection with human papillomavirus (HPV). Excessive consumption of paan (betel quid), preserved or salted foods, oral health, occupational exposure, radiation exposure, Epstein Barr virus infection, and due to hereditary causes are some of the other factors that can cause head and neck cancer.

According to the National Center for Biotechnology Information, head and neck cancer is the sixth-most common cancer worldwide, with around 630,000 new patients diagnosed every year, in turn resulting in over 350,000 deaths. Symptoms include a change or hoarseness in the voice, a lump or sore that does not heal, sore throat that does not go away, and unexplained and prolonged trouble swallowing. Around 75% of head and neck cancers are associated with tobacco use, including smokeless tobacco. Infection with HPV is a risk factor for some head and neck cancers.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/530

Head and neck cancer market segmentation:

Based on disease indication, the global head and neck cancer market is classified into:

• Laryngeal and Hypopharyngeal Cancer
• Nasal Cavity and Paranasal Sinus Cancer
• Nasopharyngeal Cancer
• Oral and Oropharyngeal Cancer
• Salivary Gland Cancer

Based on diagnostic methods, the global head and neck cancer market is classified into:

• Diagnostic imaging equipment
• Endoscopy screening equipment
• Bioscopy screening tests
• Blood tests
• Dental diagnostic

Growing demand for effective and targeted treatment for increasing the survival rate

Rising demand for effective and cost-effective treatment for cancer is projected to fuel the demand for head and neck cancer. The growth is also attributed to the growing prevalence of cancer around the globe coupled with the increasing initiatives by the government subjected to the rising number of death cases due to cancer.  The survival rate of head and neck cancer has reduced from 80% to 50% in the last ten years, as currently available treatment options mainly treat the symptoms.  The introduction of targeted molecular therapy such as gene therapy, monoclonal antibodies, and antibody-drug conjugates is expected to create major growth avenues for the head and neck cancer market.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/head-and-neck-cancer-market-530

High incidence rate to offer a potential growth opportunity for the market players

Rising occurrence of head and neck cancer and a growing number of research activities to develop cost-effective treatment options are the factors that are driving the growth of the global head and neck cancer market. According to the World Health Organization, 3 – 5% of the population around the globe suffers from head and neck cancer. Moreover, worldwide approximately 550,000 new cases of head and neck cancer are diagnosed annually with almost 300,000 deaths annually. While cancer can affect people across different age groups, it is especially prevalent among people over 50 years of age. Head and neck cancer is projected to result in 13,360 fatalities (3,420 women and 9,940 men) in 2017. These types of cancers are more than twice as common among men as women.

Moreover, rising geriatric population base rate and a growing number of initiatives by government and non-governmental organizations such as Support for People with Oral and Head and Neck Cancer (SPOHNC) are expected to offer immense growth opportunity to the market.

Key players operating in the head and neck cancer market are AB Science SA, Bayer AG, Bristol-Myers Squibb Company, Acceleron Pharma, Inc., Astellas Pharma Inc., Boston Biomedical, Inc., AbbVie Inc., and AstraZeneca Plc.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837